Cargando…

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice

Aggregation of misfolded α-synuclein (α-syn) is the major component of Lewy bodies and neurites in Parkinson’s disease (PD) and related α-synucleinopathies. Some α-syn mutations (e.g., A53T) in familial PD recapitulate the α-syn pathology in transgenic mice, which supports the importance of patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Hao, Yang, Xiuli, Mao, Xiaobo, Xu, Enquan, Qi, Chen, Wang, Haibo, Brahmachari, Saurav, York, Bethany, Sriparna, Manjari, Li, Amanda, Chang, Michael, Patel, Pavan, Dawson, Valina L., Dawson, Ted M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987675/
https://www.ncbi.nlm.nih.gov/pubmed/33776654
http://dx.doi.org/10.3389/fncel.2021.656426
_version_ 1783668659712950272
author Gu, Hao
Yang, Xiuli
Mao, Xiaobo
Xu, Enquan
Qi, Chen
Wang, Haibo
Brahmachari, Saurav
York, Bethany
Sriparna, Manjari
Li, Amanda
Chang, Michael
Patel, Pavan
Dawson, Valina L.
Dawson, Ted M.
author_facet Gu, Hao
Yang, Xiuli
Mao, Xiaobo
Xu, Enquan
Qi, Chen
Wang, Haibo
Brahmachari, Saurav
York, Bethany
Sriparna, Manjari
Li, Amanda
Chang, Michael
Patel, Pavan
Dawson, Valina L.
Dawson, Ted M.
author_sort Gu, Hao
collection PubMed
description Aggregation of misfolded α-synuclein (α-syn) is the major component of Lewy bodies and neurites in Parkinson’s disease (PD) and related α-synucleinopathies. Some α-syn mutations (e.g., A53T) in familial PD recapitulate the α-syn pathology in transgenic mice, which supports the importance of pathologic α-syn in driving the pathogenesis of α-synucleinopathies. Lymphocyte activation gene 3 (Lag3) is a receptor of α-syn fibrils facilitating pathologic α-syn spread; however, the role of Lag3 in mediating the pathogenesis in α-syn transgenic mice is not clear. Here, we report that depletion of Lag3 in human α-syn A53T transgenic (hA53T) mice significantly reduces the level of detergent-insoluble α-syn aggregates and phosphorylated ser129 α-syn, and inhibits activation of microglia and astrocytes. The absence of Lag3 significantly delays disease progression and reduces the behavioral deficits in hA53T transgenic mice leading to prolonged survival. Taken together, these results show that Lag3 contributes to the pathogenesis in the α-syn A53T transgenic mouse model.
format Online
Article
Text
id pubmed-7987675
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79876752021-03-25 Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice Gu, Hao Yang, Xiuli Mao, Xiaobo Xu, Enquan Qi, Chen Wang, Haibo Brahmachari, Saurav York, Bethany Sriparna, Manjari Li, Amanda Chang, Michael Patel, Pavan Dawson, Valina L. Dawson, Ted M. Front Cell Neurosci Neuroscience Aggregation of misfolded α-synuclein (α-syn) is the major component of Lewy bodies and neurites in Parkinson’s disease (PD) and related α-synucleinopathies. Some α-syn mutations (e.g., A53T) in familial PD recapitulate the α-syn pathology in transgenic mice, which supports the importance of pathologic α-syn in driving the pathogenesis of α-synucleinopathies. Lymphocyte activation gene 3 (Lag3) is a receptor of α-syn fibrils facilitating pathologic α-syn spread; however, the role of Lag3 in mediating the pathogenesis in α-syn transgenic mice is not clear. Here, we report that depletion of Lag3 in human α-syn A53T transgenic (hA53T) mice significantly reduces the level of detergent-insoluble α-syn aggregates and phosphorylated ser129 α-syn, and inhibits activation of microglia and astrocytes. The absence of Lag3 significantly delays disease progression and reduces the behavioral deficits in hA53T transgenic mice leading to prolonged survival. Taken together, these results show that Lag3 contributes to the pathogenesis in the α-syn A53T transgenic mouse model. Frontiers Media S.A. 2021-03-10 /pmc/articles/PMC7987675/ /pubmed/33776654 http://dx.doi.org/10.3389/fncel.2021.656426 Text en Copyright © 2021 Gu, Yang, Mao, Xu, Qi, Wang, Brahmachari, York, Sriparna, Li, Chang, Patel, Dawson and Dawson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Gu, Hao
Yang, Xiuli
Mao, Xiaobo
Xu, Enquan
Qi, Chen
Wang, Haibo
Brahmachari, Saurav
York, Bethany
Sriparna, Manjari
Li, Amanda
Chang, Michael
Patel, Pavan
Dawson, Valina L.
Dawson, Ted M.
Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
title Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
title_full Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
title_fullStr Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
title_full_unstemmed Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
title_short Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
title_sort lymphocyte activation gene 3 (lag3) contributes to α-synucleinopathy in α-synuclein transgenic mice
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987675/
https://www.ncbi.nlm.nih.gov/pubmed/33776654
http://dx.doi.org/10.3389/fncel.2021.656426
work_keys_str_mv AT guhao lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT yangxiuli lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT maoxiaobo lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT xuenquan lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT qichen lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT wanghaibo lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT brahmacharisaurav lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT yorkbethany lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT sriparnamanjari lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT liamanda lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT changmichael lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT patelpavan lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT dawsonvalinal lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice
AT dawsontedm lymphocyteactivationgene3lag3contributestoasynucleinopathyinasynucleintransgenicmice